Income Statement | | | | | | | | | | | | |
| | | | | | | | | | | | Original |
TWD | Fiscal Year Ending | | Latest |
(in millions) | Dec-15 | Dec-16 | Dec-17 | Dec-18 | Dec-19 | Dec-20 | Dec-21 | Dec-22 | Dec-23 | Dec-24 | | Dec-24 |
| FY - 9 | FY - 8 | FY - 7 | FY - 6 | FY - 5 | FY - 4 | FY - 3 | FY - 2 | FY - 1 | FY | | LTM |
| | | | | | | | | | | | |
Revenue | 20,560 | 18,075 | 19,755 | 22,759 | 22,932 | 18,358 | 21,199 | 24,165 | 24,535 | 24,033 | | 24,033 |
% Growth | NA | -12.1% | 9.3% | 15.2% | 0.8% | -19.9% | 15.5% | 14.0% | 1.5% | -2.0% | | |
| | | | | | | | | | | | |
Cost of Revenue | (18,910) | (16,017) | (17,590) | (20,445) | (20,433) | (15,915) | (18,633) | (21,585) | (21,807) | (21,261) | | (21,261) |
Gross Profit | 1,649 | 2,058 | 2,165 | 2,314 | 2,500 | 2,443 | 2,566 | 2,579 | 2,728 | 2,772 | | 2,772 |
% Revenue | 8.0% | 11.4% | 11.0% | 10.2% | 10.9% | 13.3% | 12.1% | 10.7% | 11.1% | 11.5% | | 11.5% |
| | | | | | | | | | | | |
Research and Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Selling and Marketing | (1,261) | (1,255) | (1,325) | (1,388) | (1,566) | (1,541) | (1,549) | (1,651) | (1,718) | (1,802) | | (1,802) |
General and Admin | (162) | (160) | (158) | (169) | (189) | (193) | (193) | (192) | (194) | (190) | | (190) |
Other Inc / (Exp) | 313 | 174 | 122 | 109 | 189 | 289 | 223 | 181 | 160 | 152 | | 152 |
Total Operating Exp | (1,110) | (1,241) | (1,361) | (1,449) | (1,567) | (1,445) | (1,519) | (1,662) | (1,751) | (1,840) | | (1,840) |
| | | | | | | | | | | | |
Operating Income | 539 | 817 | 803 | 865 | 933 | 998 | 1,047 | 917 | 977 | 932 | | 932 |
% Revenue | 2.6% | 4.5% | 4.1% | 3.8% | 4.1% | 5.4% | 4.9% | 3.8% | 4.0% | 3.9% | | 3.9% |
| | | | | | | | | | | | |
Interest Expense | 21 | 23 | 21 | 31 | (11) | (29) | (32) | (11) | (4) | (10) | | (10) |
Pre-tax Income | 560 | 840 | 825 | 896 | 922 | 969 | 1,015 | 907 | 973 | 922 | | 922 |
Earnings of Discontinued Ops. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Provision for Taxes | (68) | (134) | (138) | (160) | (184) | (194) | (211) | (186) | (190) | (184) | | (184) |
Net Income to Company | 493 | 706 | 687 | 735 | 738 | 775 | 803 | 721 | 783 | 738 | | 738 |
% Margin | 2.4% | 3.9% | 3.5% | 3.2% | 3.2% | 4.2% | 3.8% | 3.0% | 3.2% | 3.1% | | 3.1% |
| | | | | | | | | | | | |
Minority Interest in Earnings | 0 | 0 | 0 | 0 | 0 | 18 | 7 | 4 | 0 | 0 | | 0 |
Net Income to Stockholders | 493 | 706 | 687 | 735 | 738 | 793 | 811 | 725 | 783 | 738 | | 738 |
| | | | | | | | | | | | |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Other Adj. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
| | | | | | | | | | | | |
Net Income to Common | 493 | 706 | 687 | 735 | 738 | 793 | 811 | 725 | 783 | 738 | | 738 |
% Margin | 2.4% | 3.9% | 3.5% | 3.2% | 3.2% | 4.3% | 3.8% | 3.0% | 3.2% | 3.1% | | 3.1% |
| | | | | | | | | | | | |
As Reported | | | | | | | | | | | | |
Basic EPS (Continuing Ops) | 1.59 | 2.28 | 2.22 | 2.38 | 2.39 | 2.57 | 2.62 | 2.35 | 2.53 | 2.39 | | 2.39 |
Diluted EPS (Continuing Ops) | 1.59 | 2.27 | 2.21 | 2.37 | 2.37 | 2.56 | 2.61 | 2.34 | 2.53 | 2.38 | | 2.38 |
| | | | | | | | | | | | |
WA Basic Shares Out. | 309.04 | 309.04 | 309.04 | 309.04 | 309.04 | 309.04 | 309.04 | 309.04 | 309.04 | 309.04 | | 309.04 |
WA Diluted Shares Out. | 310.64 | 310.73 | 311.15 | 310.56 | 310.64 | 310.23 | 310.33 | 310.23 | 309.94 | 310.04 | | 310.04 |
| | | | | | | | | | | | |
EBITDA, EBIT Reconciliation | | | | | | | | | | | | |
EBT, Incl. Unusual Items | 560 | 840 | 825 | 896 | 922 | 969 | 1,015 | 907 | 973 | 922 | | 922 |
Addback: Net Interest Expense | (21) | (23) | (21) | (31) | 11 | 29 | 32 | 11 | 4 | 10 | | 10 |
Addback: Other Non Operating Expenses, Total | (123) | (156) | (142) | (116) | (193) | (297) | (207) | (195) | (157) | (150) | | (150) |
Addback: Depreciation & Amortization | 122 | 104 | 106 | 109 | 136 | 153 | 188 | 201 | 193 | 200 | | 200 |
Addback: Restructuring Charges | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Merger / Acquisition Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Goodwill Impairment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Gain (Loss) On Sale Of Invest. | 18 | 18 | (3) | 0 | 0 | 0 | 0 | 13 | (7) | 0 | | 0 |
Addback: Gain (Loss) On Sale Of Assets | (209) | (36) | 2 | 7 | 4 | 11 | (16) | 2 | 5 | 7 | | 7 |
Addback: Asset Writedown | 1 | 0 | 21 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: In Process R&D Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Insurance Settlements | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Legal Settlements | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Other Unusual Items | 0 | 0 | 0 | 0 | (0) | (2) | (0) | (1) | (1) | (9) | | (9) |
Adjusted EBITDA | 348 | 747 | 788 | 865 | 880 | 862 | 1,012 | 938 | 1,009 | 980 | | 980 |
% Margin | 1.7% | 4.1% | 4.0% | 3.8% | 3.8% | 4.7% | 4.8% | 3.9% | 4.1% | 4.1% | | 4.1% |
| | | | | | | | | | | | |
Adjusted EBIT | 227 | 643 | 682 | 757 | 744 | 709 | 823 | 736 | 816 | 780 | | 780 |
% Margin | 1.1% | 3.6% | 3.5% | 3.3% | 3.2% | 3.9% | 3.9% | 3.0% | 3.3% | 3.2% | | 3.2% |
| | | | | | | | | | | | |
Adjusted Net Income Reconciliation | | | | | | | | | | | | |
Net Income to Company | 493 | 706 | 687 | 735 | 738 | 775 | 803 | 721 | 783 | 738 | | 738 |
Addback: Unusual Items | (190) | (18) | 20 | 7 | 4 | 9 | (16) | 14 | (3) | (3) | | (3) |
Less: Tax Benefit of Unusual Items (26%) | 49 | 5 | (5) | (2) | (1) | (2) | 4 | (4) | 1 | 1 | | 1 |
Adjusted Net Income | 352 | 693 | 702 | 741 | 741 | 781 | 791 | 731 | 781 | 736 | | 736 |
% Margin | 1.7% | 3.8% | 3.6% | 3.3% | 3.2% | 4.3% | 3.7% | 3.0% | 3.2% | 3.1% | | 3.1% |